About Parkwalk
Parkwalk is a venture capital firm founded in 2009. It is primarily based out of London, United Kingdom. As of Nov 2025, Parkwalk is an active investor, having invested in 168 companies, with 4 new investments in the last 12 months. It primarily invests in Series A round in United Kingdom based startups. Its investments are spread across a wide range of sectors from High Tech to Enterprise Applications and Life Sciences. Most recently it participated in the $***** Seed round of Scripta Therapeutics Overall, Parkwalk portfolio has seen 1 unicorn, 8 IPOs and 22 acquisitions including key companies like Horizon Discovery, Cytora and Nyobolt. A lot of funds co-invest with Parkwalk, with names like IP Group sharing a substantial percentage of its portfolio. Parkwalk has team of 24 people including 3 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 4 more
Portfolio IPOs
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Parkwalk's List of Top Investments
Parkwalk has a portfolio of 168 companies, one of which is a Unicorn. Their most notable investments are in Psyomics and Psyomics.Their portfolio spans across United Kingdom, United States, Mexico and 1 more locations. They have invested in High Tech, Enterprise Applications, Life Sciences and 31 other sectors, across stages such as Seed, Series A and 4 more. Here is the list of top investments by Parkwalk:
Developer of cell lines with genetic modification using AAV gene-editing platform. The company has cell line engineering, knockout cell lines, and reporter cell lines. It also provides services in T cell activation assay, lymphocyte reaction assay, T cell-mediated tumor cell lysis assay, ADCC, and CDC assays, gene-editing for immuno-oncology, CRISPR Screening, drug combination screening, in vitro assay, and in-vivo assay.
Key facts about Horizon Discovery
- Founded Year: 2007
- Location: Cambridge (United Kingdom)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $46.3M
- Employee Count: 94 as on Apr 30, 2026
- Investors: ValueAct Capital, Draper Esprit and 13 Others
- Latest Funding Round: Post IPO, Sep 07, 2018, $*****
- Highlight: Acquired
2. Oxa
Developer of autonomous software and hardware for industrial vehicle fleets. This technology enables self-driving capabilities for various industrial vehicles through modular hardware systems. The software integrates with fleet management tools to coordinate vehicle operations and logistics. These systems facilitate automated movement within industrial environments to improve operational efficiency.
Key facts about Oxa
- Founded Year: 2014
- Location: Oxford (United Kingdom)
- Annual Revenue: £1M - £10M as on Dec 31, 2024
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $349M
- Employee Count: 380 as on May 31, 2026
- Investors: BP Ventures, Google and 25 Others
- Latest Funding Round: Series D, Mar 04, 2026, $*****
- Highlight: Editors' Pick
3. Cytora
Risk management solutions for insurers and underwriters. It provides risk digitization by extraction data points, risk evaluation by evaluating portfolio strategies, and more. It also allows integration of data sources, defining rules, and optimizing risk flows.
Key facts about Cytora
- Founded Year: 2012
- Location: London (United Kingdom)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $41.5M
- Employee Count: 138 as on May 31, 2026
- Investors: Starr Companies, Cambridge Enterprise and 41 Others
- Latest Funding Round: Series B, Apr 17, 2019, $*****
- Highlight: Acquired
4. Riverlane
Provider of software for quantum computers. It provides computing elements in the stack accessible like CPU, FPGAs and qubits, and quantum error correction. It also can be used in measurement strategies, noise models, and algorithms.
Key facts about Riverlane
- Founded Year: 2016
- Location: Cambridge (United Kingdom)
- Annual Revenue: £1M - £10M as on Dec 31, 2024
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $122M
- Employee Count: 193 as on May 31, 2026
- Investors: EDBI, Molten Ventures and 17 Others
- Latest Funding Round: Series C, Aug 06, 2024, $*****
- Highlight: Editors' Pick
Manufacturer of niobium-based anode material for lithium-ion batteries and cells. The material enables fast charging, long cycle life, and safety for heavy-duty applications. It supplies anode active material to cell manufacturers and demonstrator cells to OEMs for evaluation. The company supports product development with its team of scientists and engineers.
Key facts about Echion Technologies
- Founded Year: 2017
- Location: Sawston (United Kingdom)
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $92.4M
- Employee Count: 50 as on Mar 31, 2025
- Investors: Origin Capital, BGF and 35 Others
- Latest Funding Round: Series B, Nov 14, 2024, $*****
- Highlight: Editors' Pick
Parkwalk's Year-on-Year Investment Trends
Parkwalk has invested in 168 companies over the last 16 years, with an average of 8 new investments annually in the last 10 years. In 2025, it made 9 investments. Its most recent first time investment was in Scripta Therapeutics and most recent follow-on round was in PhaseCraft.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 4 | 5 | 9 |
2024 | 6 | 7 | 13 |
2023 | 5 | 8 | 13 |
2022 | 6 | 9 | 15 |
2021 | 4 | 9 | 13 |
2020 | 6 | 11 | 17 |
2019 | 8 | 13 | 21 |
2018 | 14 | 13 | 27 |
2017 | 19 | 7 | 26 |
Parkwalk's Investments by Stage
Parkwalk has made 69 investments in Seed stage with an average round size of $2.47M, 41 investments in Series A stage with an average round size of $7.05M and 11 investments in Series B stage with an average round size of $13.6M.Stage of entry | No. of Investments |
|---|---|
Seed | 69 |
Series A | 41 |
Series B | 11 |
Post IPO | 6 |
PE | 3 |
Others | 3 |
Note: We have considered here, only first round of investments
Parkwalk's Investments by Sector
Parkwalk has a diverse portfolio, with companies operating in the High Tech, Life Sciences, Enterprise Applications, Semiconductors and Sustainability Tech. Notably, it has invested in 146 Enterprise (B2B) companies, 146 Tech companies, 68 Software companies and at least 58 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
High Tech | 50 |
Life Sciences | 43 |
Enterprise Applications | 41 |
Semiconductors | 20 |
Sustainability Tech | 18 |
Others | 123 |
Note: We have considered here, only first round of investments
Parkwalk's Investments by Geography
Parkwalk has made most investments in United Kingdom (125), followed by United States where it has made 5 investments.Country | No. of Investments |
|---|---|
United Kingdom | 125 |
United States | 5 |
Mexico | 1 |
Taiwan | 1 |
Note: We have considered here, only first round of investments
Parkwalk's recent investments
Parkwalk has not made any investment in 2026 so far.Here are the most recent investments by Parkwalk:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Nov 12, 2025 | United Kingdom | Seed | 9861 | ||
Sep 30, 2025 | United Kingdom | Series A | 8891 | [+4] | |
Sep 17, 2025 | United Kingdom | Series A | 9632 | [+1] | |
Sep 02, 2025 | United Kingdom | Series B | 3871 | [+4] | |
Jul 23, 2025 | United Kingdom | Series A | 2761 | [+3] |
Unicorns in Parkwalk's Portfolio
Parkwalk has 1 unicorn in its portfolio - Nyobolt. The most recent unicorn in their portfolio is Nyobolt which became a unicorn in 2026.Here is a list of unicorns in Parkwalk's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
63 | Developer of battery technology for high-power, integrated energy systems | 2019 | Cambridge | Series C | zadbqyk |
IPOs and Publicly Listed companies in Parkwalk's Portfolio
8 of Parkwalk's portfolio companies have become public. Mirriad got listed on the London Stock Exchange (LSE), in Dec 2017 at marketcap of $85.9M and Hydrofinity got listed on the London Stock Exchange (LSE).Here are Parkwalk's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 19, 2017 | May 2015 | Series C | 3134 | |
Mar 25, 2014 | - | - | 3910 | |
Jul 10, 2012 | Apr 2011 | Series B | 6363 | |
Apr 11, 2011 | Mar 09, 2017 | Post IPO | 4334 | |
May 14, 2010 | Oct 18, 2016 | Post IPO | 1109 |
Acquired companies in Parkwalk's Portfolio
22 companies from Parkwalk's portfolio have been acquired. The most recent acquisition was Cytora in Sep 2025 by Applied for $*****.Here are Parkwalk's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 09, 2025 | Oct 01, 2015 | Series A | 3158 | |
Sep 02, 2025 | Feb 27, 2017 | Series B | 5561 | |
Dec 19, 2024 | Oct 01, 2017 | Post IPO | 5488 | |
Jul 08, 2024 | - | - | 7453 | |
Nov 24, 2023 | - | - | 5555 |
Team profile of Parkwalk
Parkwalk has a team of 24 members including 3 Partners, 1 Venture Partner and 13 Principals located in United Kingdom. Parkwalk's team does not sit on the board of any company as of now.Here is a list of top team members in Parkwalk:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | London | - | - | |
Partner | London | |||
Partner | - | - | ||
Venture Partner | Derby | - | - | |
Principal | London | - | ||
Principal | London | Oxford Flow, Inflowmatix and 1 more | - | |
Principal | London | - | ||
Principal | London | - | ||
Principal | London | - | - | |
Principal | United Kingdom | - | ||
Principal | London | - | - |
Co-investors of Parkwalk
Over the past 16 years, 482 investors have co-invested in Parkwalk's portfolio companies. This includes funds and angels.
- Invested before Parkwalk: IP Group, Cambridge Enterprise and 119 others have invested in rounds before Parkwalk. There are 11 companies where IP Group has invested before Parkwalk and 6 companies where Cambridge Enterprise has invested before Parkwalk.
- Top Co-investors of Parkwalk: 112 investors entered a company along with Parkwalk. These include investors like IP Group (11 companies).
- Invested after Parkwalk: A total of 249 investors have invested in Parkwalk's portfolio after their investments. Top Investors include Europa (15 companies), BGF (12 companies) and Gov (11 companies).
Recent News related to Parkwalk
•
UK's Scripta Therapeutics secures over €10 million to revolutionize drug discoveryEU-Startups•Nov 13, 2025•Oxford Science Enterprises, Apollo Health Ventures, Scripta Therapeutics, YZR Capital and 3 others
•
Startup developing ‘liquid bandages’ raises £4.8mUKTN•Sep 30, 2025•NoBACZ, ACF Investors, University of Cambridge, Cambridge Enterprise and 4 others
•
NoBACZ Healthcare Raises £4.8M in FundingFinSMEs•Sep 30, 2025•NoBACZ, ACF Investors, University of Cambridge, The FSE Group and 3 others
•
Enhanced Genomics Secures €16 Million To Accelerate Therapeutics Pipeline DevelopmentStartup Rise EU•Sep 17, 2025•Meltwind Advisory, Elegen, BGF, Parkwalk
•
•
Cambridge biotechnology company extends Series A funding to $19mInsider Media•Sep 17, 2025•Meltwind Advisory, BGF, Parkwalk, Enhanced Genomics
•
British startup Phasecraft raises €29 million to advance quantum computing solutionsEU-Startups•Sep 02, 2025•PhaseCraft, Plural, Novo Holdings, Playground and 4 others
•
Phasecraft Raises $34M in Series B FundingFinSMEs•Sep 02, 2025•Plural, PhaseCraft, AlbionVC, Parkwalk and 5 others
•
Northern Gritstone & Parkwalk launch Northern Universities Venture Fund.Prolific North•Jun 20, 2025•Parkwalk, Northern Gritstone
•
